The 100,000 Genomes Project was launched in late 2012 by Genomics England and is now nearing completion. With the bold aims of creating a new genomic medicine service for the NHS and transforming the way people are cared for, the question arises – what happens next?
Following on from the 100,000 Genomes Project, NHS England is beginning to implement its genomic medicine programme, which will include a reconfiguration of laboratories and a new directory of tests that will be available nationally.
In this webinar, we’ll hear from Alexandra Pickard and John Paul Maytum of NHS England Genomics on what the new genomic medicine programme looks like and how it will effect you and your members. Registration for the webinar
is open to our members now.
– Alexandra Pickard (Policy and Strategy Lead, Genomics Unit at NHS England)
– John Paul Maytum (Engagement Lead, Genomics Lead at NHS England)
– Dr Jayne Spink (Chief Executive, Genetic Alliance UK)
– Nick Meade (Director of Policy, Genetic Alliance UK)
What is the 100,000 Genomes Project?
The 100,000 Genomes Project was set up by Genomics England and funded by the Department of Health & Social Care, to sequence 100,000 whole genomes from NHS patients. Its four main aims are:
– to create an ethical and transparent programme based on consent
– to bring benefit to patients and set up a genomic medicine service for the NHS
– to enable new scientific discovery and medical insights
– to kick start the development of a UK genomics industry.
For more information, see the Genomics England website.